GoHealth Q3 net loss narrows to $56.2M; submissions jump 31% YoY

GoHealth, Inc.

2023-Q3 EPS reported -$7.04 revenue$457,974,000

Q3 2023 net revenues $132.0M vs $133.1M YoY; net loss improved to $56.2M from $74.7M.
Submissions increased 31% to 161,550 from 122,964 in prior year period.
Adjusted EBITDA loss narrowed to $11.5M from $14.3M; YTD Adjusted EBITDA positive $18.1M vs negative $35.0M.
TTM cash flow from operations improved to -$3.2M from -$124.7M; $72M of partner payments received after quarter-end.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GoHealth, Inc. reported the three months ended September 30, 2023 results: revenue $132.0 million, net income $56.2 million net loss.

Period: the three months ended September 30, 2023
Revenue: $132.0 million
Net income: $56.2 million net loss
Result: reported results

Exact text from the filing

Third quarter 2023 net revenues of $132.0 million, compared to $133.1 million in the prior year period; YTD 2023 net revenues of $458.0 million, a decrease of $104.3 million compared to $562.3 million in the prior year period.

View on SEC.gov

Browse all earnings releases →

GoHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001808220-23-000099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.